Global Core Electronic Medicinal Product Information (ePI), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Composition - Type 2 Paracetamol

Raw json | Download

{
  "resourceType" : "Composition",
  "id" : "composition-epi-type2-example-paracetamol",
  "meta" : {
    "versionId" : "1",
    "lastUpdated" : "2023-01-25T10:00:00Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/composition-epi-type1"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Package Leaflet: Information for the user - Paracetamol Tablets</p></div>"
  },
  "contained" : [
    {
      "resourceType" : "Binary",
      "id" : "binaryImage-t2",
      "meta" : {
        "profile" : [
          🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/binary-epi"
        ]
      },
      "contentType" : "image/png",
      "data" : "iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mNkYAAAAAYAAjCB0C8AAAAASUVORK5CYII="
    }
  ],
  "identifier" : [
    {
      "system" : "http://example.org/identifier",
      "value" : "composition-epi-type2-example-paracetamol"
    }
  ],
  "version" : "1.0",
  "status" : "final",
  "type" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/rmswi",
        "code" : "100000155538",
        "display" : "Package Leaflet"
      }
    ]
  },
  "subject" : [
    {
      🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"
    }
  ],
  "date" : "2023-01-25",
  "author" : [
    {
      🔗 "reference" : "Organization/org-epi-type2-example-acme"
    }
  ],
  "title" : "Package Leaflet: Information for the user - WonderDrug 500 mg tablets",
  "section" : [
    {
      "id" : "root-section",
      "title" : "Package Leaflet",
      "code" : {
        "coding" : [
          {
            "system" : "https://spor.ema.europa.eu/rmswi",
            "code" : "100000155538",
            "display" : "Package Leaflet"
          }
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\">Package Leaflet</div>"
      },
      "entry" : [
        {
          🔗 "reference" : "Organization/org-epi-type2-example-acme"
        },
        {
          🔗 "reference" : "MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"
        }
      ],
      "section" : [
        {
          "id" : "section-1",
          "title" : "1. What is in this leaflet",
          "code" : {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/rmswi",
                "code" : "100000155538",
                "display" : "1. What is in this leaflet"
              }
            ]
          },
          "text" : {
            "status" : "generated",
            "div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><h2>1. What is in this leaflet</h2><p>Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.</p></div>"
          }
        }
      ]
    }
  ]
}